torcetrapib has been researched along with Body Weight in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
André, A; Briand, F; Ouguerram, K; Sulpice, T; Thieblemont, Q | 1 |
1 other study(ies) available for torcetrapib and Body Weight
Article | Year |
---|---|
CETP inhibitor torcetrapib promotes reverse cholesterol transport in obese insulin-resistant CETP-ApoB100 transgenic mice.
Topics: Animals; Anticholesteremic Agents; Apolipoprotein B-100; Bile Acids and Salts; Biological Transport; Body Weight; Cells, Cultured; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Dyslipidemias; Humans; Insulin Resistance; Lipoproteins; Macrophages; Male; Mice; Mice, Transgenic; Obesity; Quinolines | 2011 |